Programmed cell death 4 (Pdcd4) is a tumor suppressor that inhibits neoplastic transformation and tumor invasion. Tissue microarray analysis showed that Pdcd4 expression is downregulated in colon adenocarcinoma and carcinoma relative to adjacent normal tissues. To address the issue of whether reduced Pdcd4 expression is sufficient to promote tumor progression, we knocked down Pdcd4 expression in colon tumor HT29 cells using pdcd4 short hairpin RNA (shRNA). Pdcd4 knockdown results in a fibroblast-like transition, while the control cells (expressing LacZ shRNA) remain as clumped similar to the parental cells. In addition, expression of pdcd4 shRNA in HT29 cells promotes invasion. In an effort to characterize the molecular mechanism underlying these observations, we discovered that knockdown of Pdcd4 results in reduction of E-cadherin expression, and accumulation of active b-catenin in the nucleus. The active b-catenin binds with T-cell factor 4 (Tcf4) and activates b-catenin/ Tcf-dependent transcription. Furthermore, Pdcd4 knockdown dramatically increases AP-1-dependent transcription. Thus, the mechanism by which reduced Pdcd4 expression promotes invasion appears to involve the activation of b-catenin/Tcf and AP-1-dependent transcription.
Introduction
Programmed cell death 4 (Pdcd4) is a novel tumor suppressor, inhibiting tumor promotion and progression in both cultured cells and transgenic mice. Elevating Pdcd4 protein levels by overexpressing sense pdcd4 inhibits both TPA-induced transformation in P þ cells, and the expression of a tumor phenotype in transformed JB6 cells (Yang et al., 2001 (Yang et al., , 2003b . In addition to cultured cells, Pdcd4 transgenic mice that overexpress Pdcd4 in the epidermis show significant reductions in 7,12-dimethylbenz(a)anthracene/TPA-induced skin papilloma formation, carcinoma incidence and papilloma-carcinoma conversion frequency when compared with wild-type mice (Jansen et al., 2005) . These findings suggest that Pdcd4 suppresses carcinogenesis not only at an early stage (tumor promotion), but also at a late stage (tumor progression) in both cultured cells and transgenic mice.
Overexpression of pdcd4 cDNA in the invasive colon tumor cell line, RKO cells, significantly reduces its invasive capacity (Yang et al., 2006a) . Pdcd4 suppresses invasion by specifically inhibiting AP-1-dependent transcription, but not serum response element-dependent transcription (Yang et al., 2006a) . Pdcd4 inhibits AP-1-dependent transcription by inhibiting the c-Jun activation via the JNK signaling pathway (Yang et al., 2006a) . Overexpression of a dominant-negative MAP4K1, a kinase upstream of the JNK signaling pathway, inhibits c-Jun activation and invasion in RKO cells (Yang et al., 2006a) . In addition, overexpression of pdcd4 cDNA in RKO cells inhibits intravasation and urokinasetype plasminogen activator receptor (uPAR) expression (Leupold et al., 2007) . uPAR is a cell surface protein, which mediates degradation of extracellular matrix components and promotes tumor cell invasion and metastasis (Laufs et al., 2006) . These findings collectively demonstrated the inhibitory role of Pdcd4 in colon tumor cell invasion.
Pdcd4 expression is downregulated in several human cancers. Analyses of protein and/or mRNA levels in human tumor tissues of lung (Chen et al., 2003) , liver (Zhang et al., 2006) , ovary (Bonome et al., 2005) , skin (Matsuhashi et al., 2007) and brain (Gao et al., 2007) revealed that Pdcd4 expression in these tumor tissues is lower than those in adjacent normal tissues. Likewise, protein expression patterns frequently show reduced Pdcd4 protein level in more progressed tumor cell lines (Jansen et al., 2004) . Although these findings indicate downregulation of Pdcd4 expression correlates with tumor cell progression, it is unknown whether loss of Pdcd4 expression is sufficient to promote tumor progression, and, if so, the underlying molecular mechanism is not clear.
In the present study, we sought to determine the role of Pdcd4 in tumor invasion and elucidate the involved molecular events. We stably knocked down the Pdcd4 expression in colon tumor cells, and found that Pdcd4 knockdown triggers fibroblast-like morphological changes and enhances invasion. Furthermore, knockdown of Pdcd4 expression stimulates the translocation of b-catenin into nuclei, and activates b-cateninsol;T cell factor (Tcf)-dependent transcription, as well as AP-1-dependent transcription. Our study is the first characterization of the biological and molecular consequences when Pdcd4 is downregulated in colon tumor cells.
Results
Pdcd4 expression is downregulated in human colon cancer tissues To determine the Pdcd4 expression level in the human colon cancer tissues, we assayed 86 samples of human colon adenocarcinoma and carcinoma tissues from stage II to stage IV and corresponding adjacent normal colon tissues. Slides containing normal or cancerous colon tissues were stained with Pdcd4 antibody to show the Pdcd4 protein levels (brown), and counterstained with hematoxylin to locate nucleus (blue) (Figure 1 ). Of those tumor samples, 74 cases (86%) exhibited no relevant Pdcd4 staining, nine cases (10.5%) showed weak staining, and the remaining three cases (3.5%) displayed moderate to strong staining (Table 1) (Table 1) . Pdcd4 staining is prominent in the epithelium and lamina propria of normal colon tissues (Figure 1a ). Pdcd4 staining is observed in both the cytoplasm and nucleus of the epithelium (lower panel of Figure 1b ), but only observed in the nucleus of the lamina propria (indicated by arrows in Figure 1b) . The control experiment with non-immune antibody showed no specific staining in normal colon tissues (Figure 1c) . These results indicate that Pdcd4 expression is downregulated in colon cancer tissues.
Pdcd4 knockdown leads to a fibroblast-like transition and promotes invasion Analyses of the Pdcd4 expression levels in cancerous colon tissues (Table 1) and cell lines (Supplementary Figure S1 ) suggest that Pdcd4 expression is downregulated Figure S2) . To delineate whether Pdcd4 knockdown promotes cell invasion, we performed Matrigel invasion assays. As shown in Figure 3 , more HT29-shPdcd4 cells penetrated the Matrigel barrier than HT29-shLacZ and HT29 cells did. The invasive ability of HT29-shPdcd4 cells was approximately 11-fold higher than that of HT29-shLacZ cells, while HT29-shLacZ and HT29 cells displayed a similar invasive capacity. These findings indicate that diminished Pdcd4 expression promotes invasion in colon tumor HT29 cells.
Pdcd4 knockdown results in suppression of E-cadherin expression E-cadherin is a trans-membrane glycoprotein, whose cytoplasmic domain interacts with actin, cytoskeleton through a-catenin, p120 and b-catenin (Kemler, 1992) . Since E-cadherin plays a major role in cell-cell adhesion in epithelial cells (Takeichi, 1991) , loss of cell-cell interaction upon Pdcd4 knockdown ( Figure 2b ) led us to investigate the E-cadherin expression in Pdcd4 knockdown cells. E-cadherin protein levels in HT29 and HT29-shLacZ cells were similar and were approximately 13 to 14-fold higher than that in HT29-shPdcd4 cells ( Figure 4a ). In agreement with the protein levels, the mRNA levels of E-cadherin in HT29-shLacZ cells were approximately 12-fold higher than that in HT29-shPdcd4 cells (Figure 4b ). Likewise, knockdown of Pdcd4 in GEO cells also downregulated E-cadherin expression at both protein and mRNA levels (Supplementary Figure S3 ). These findings indicate that Pdcd4 knockdown results in suppression of E-cadherin expression at mRNA and protein levels.
To test the role of E-cadherin in modulating invasion of the Pdcd4 knockdown cells, we overexpressed E-cadherin in HT29-shPdcd4 cells and tested whether overexpression of E-cadherin will reverse the invasive capacity. As shown in Figure 5a , the protein level of Knockdown of Pdcd4 promotes invasion Q Wang et al E-cadherin in E-cadherin-overexpressing HT29-shPdcd4 cells (E-cad) was approximately twofold higher than that in empty vector-expressing HT29-shPdcd4 cells (control). However, the invasive capacity of E-cad cells was about 35% of that in control cells ( Figure 5b ). This finding indicates that overexpression of E-cadherin protein reverses the invasive capacity of Pdcd4 knockdown cells. Thus, E-cadherin is a critical modulator in Pdcd4 suppressing invasion of colon tumor cells.
Active b-catenin accumulates in the nuclei of Pdcd4 knockdown cells Upon loss of binding with E-cadherin, free b-catenin is rapidly phosphorylated by glycogen synthase kinase-3b (GSK-3b) in the adenomatous polyposis coli (APC)-axin-GSK-3b-casein kinase I complex, and degraded by the proteasome pathway. If the APC is mutated or GSK-3b activity is blocked by Wnt signaling, b-catenin will not be phosphorylated at its N-terminus (the active form), and translocate to nucleus (Gregorieff and Three independent experiments were performed with triplicates for each sample every time. Results are expressed as mean±s.d. of three independent experiments. The E-cadherin/GAPDH ratio of HT29-shLacZ cells is designated as 100%. The asterisk indicates a significant difference determined by one-way ANOVA (Po0.001).
Knockdown of Pdcd4 promotes invasion Q Wang et al Clevers, 2005) . To investigate whether the decrease in E-cadherin expression by Pdcd4 knockdown alters the b-catenin protein level, we determined the total b-catenin protein level by immunoblotting analysis. The b-catenin protein level in HT29-shPdcd4 was slightly lower than that in HT29-shLacZ and HT29 cells (Figure 4a ). The decrease in the b-catenin protein level in HT29-shPdcd4 cells might be attributed to its degradation, since proteasome degradation of b-catenin is not completely inhibited by APC mutation in HT29 cells (Yang et al., 2006b) . Next, we explored whether the b-catenin released from E-cadherin translocates into the nucleus. Membrane, cytoplasmic (containing membrane inner-surfaceassociated proteins and soluble cytoplasmic proteins) and nuclear extracts were isolated from HT29-shLacZ and HT29-shPdcd4 cells, and the active b-catenin protein level was determined. As shown in Figure 6a , active b-catenin clearly appeared in the nuclear extracts of HT29-shPdcd4, but it was almost undetectable in that of HT29-shLacZ cells. In contrast, the active b-catenin presented in the cytoplasmic extracts of HT29-shLacZ cells, but not in that of HT29-shPdcd4 cells. In addition, the active b-catenin was not detected in the membrane extracts of either the HT29-shLacZ or HT29-shPdcd4 cells. Tcf4 and GAPDH were used as nuclear and cytoplasmic markers, respectively. Both marker proteins were enriched in the appropriate fraction. There is a similar amount of GAPDH presented in the membrane extracts suggesting an equal loading of membrane extracts. In addition, in situ immunofluorescent staining with anti-active b-catenin antibody also demonstrated that active b-catenin accumulated in the nuclei of HT29-shPdcd4 cells (Figure 6b) . These findings collectively demonstrate that active b-catenin accumulates in the nucleus upon reduction of Pdcd4 expression.
Active b-catenin binds with Tcf4 and activates b-catenin/ Tcf-dependent transcription in Pdcd4 knockdown cells The Tcf/LEF (T-cell factor/lymphoid enhancer factor) transcription factor family consists of four members, Tcf1, Tcf3, Tcf4 and LEF1. Subsequent to translocation to the nucleus, b-catenin binds with a member of Tcf/LEF family to form b-catenin/Tcf complex and activate b-catenin/Tcf-dependent transcription. It has been reported that b-catenin-Tcf4 complex accumulates in colon tumor cells (Morin et al., 1997) . To determine whether b-catenin interacts with Tcf4 in HT29-shPdcd4 cells, we performed co-immunoprecipitations using a Tcf4 antibody. As shown in Figure 7a , the Tcf4 antibody, but not pre-immune serum, co-immunoprecipitated active b-catenin from the nuclear extracts of HT29-shPdcd4 cells. In contrast, co-immunoprecipitation of active b-catenin was undetectable using the nuclear extracts of HT29-shLacZ cells. The nuclear extracts of the HT29-shLacZ and HT29-shPdcd4 cells yielded similar band intensities for Tcf4, indicating that Knockdown of Pdcd4 promotes invasion Q Wang et al both cell lines have similar levels of Tcf4 protein and similar efficiency of immunoprecipitation. In addition, we also tested whether Tcf1, Tcf3 and LEF1 antibodies could co-immunoprecipitate active b-catenin; no coimmunoprecipitation of b-catenin was detected using these antibodies (data not shown).
To test the functional significance of nuclear accumulation of b-catenin in Pdcd4 knockdown cells, we performed reporter assays using TOPflash and FOPflash reporter constructs, which contain wild type and mutated b-catenin/Tcf binding sites, respectively. As shown in Figure 7b , b-catenin/Tcf-dependent transcription was approximately 22-fold higher in HT29-shPdcd4 cells than that in HT29-shLacZ cells. When HT29-shLacZ and HT29-shPdcd4 cells were transfected with the FOPflash reporter construct, the b-catenin/Tcfdependent transcription was decreased comparing with that of cells transfected with TOPflash reporter. These data clearly show that Pdcd4 knockdown stimulates the binding between b-catenin and Tcf4 and activates b-catenin/Tcf-dependent transcription.
Knockdown of Pdcd4 expression activates AP-1-dependent transcription and stimulates c-Jun expression
Previously, we and others have demonstrated that overexpression of Pdcd4 inhibits AP-1-dependent transcription by inhibiting c-Jun activation (Yang et al., 2003b (Yang et al., , 2006a Bitomsky et al., 2004) . To examine whether knockdown of Pdcd4 expression activates AP-1-dependent transcription, 4 Â AP-1 luciferase reporter (4 Â AP-1-LUC) construct was transfected into HT29-shLacZ and HT29-shPdcd4 cells. The AP-1-dependent transcription was approximately 40-fold higher in HT29-shPdcd4 cells than that in HT29-shLacZ cells (Figure 8a ). In contrast, the NF-kB-dependent transcription was only 2-fold higher in HT29-shPdcd4 cells than that in HT29-shLacZ cells (Figure 8a ). The NF-kB luciferase reporter (NF-kB-LUC) was transfected into HT29-shLacZ and HT29-shPdcd4 cells to serve as the specificity control. These results suggest that Pdcd4 knockdown primarily activates AP-1-dependent transcription, while activation of NF-kB-dependent transcription might be due to the cross-talk between the AP-1 and NF-eˆB protein complexes (Li et al., 1998) . 
Knockdown of Pdcd4 promotes invasion Q Wang et al
To test whether activation of AP-1-dependent transcription is through activating c-Jun and JNK, immunoblotting analyses were performed with various antibodies. The level of phospho-c-Jun in the HT29-shLacZ and HT29-shPdcd4 cells was barely detectable, yet similar between the two cell lines (Figure 8b) . However, the level of total c-Jun in HT29-shPdcd4 was approximately 3-fold higher than that in HT29-shLacZ cells (Figure 8b) . Although the level of phospho-ERK was also similar in both HT29-shLacZ and HT29-shPdcd4 cells, phospho-JNK and phospho-p38 were undetectable (data not shown). These results indicate that stimulation of c-Jun expression may contribute to the activation of AP-1-dependent transcription in HT29-shPdcd4 cells. These findings also suggest that overexpression and knockdown of Pdcd4 may target different molecules for modulating AP-1-dependent transcription.
Discussion
In this study, we demonstrate that stably knockdown of Pdcd4 expression results in morphological changes and promotes invasion in colon tumor cells. Moreover, knockdown of Pdcd4 significantly activates both b-catenin/Tcf and AP-1-dependent transcription.
Downregulation of the tumor suppressor Pdcd4 expression is frequently observed in many types of cancers. Here, we demonstrated that Pdcd4 expression is also downregulated in the human colon cancer tissues ( Figure 1 and Table 1 ) and invasive colon tumor cell lines (Supplementary Figure S1) . In line with this, Lee et al. (2006) analysed two human samples and found that Pdcd4 expression is sequentially downregulated as the tissues progress from normal to adenoma to carcinoma. These findings suggest that Pdcd4 is a potential biomarker for evaluating the transition from normal to adenoma and carcinoma in colon cancer.
We demonstrated that Pdcd4 knockdown results in fibroblast-like morphological changes (Figure 2 and Supplementary Figure S2) , and enhancement of invasion (Figure 3 ). These phenotypic changes are attributed, at least in part, to the downregulation of E-cadherin expression (Figure 4 and Supplementary Figure S3) since elevating E-cadherin protein level in HT29-shPdcd4 suppresses invasion ( Figure 5 ). It has been proposed that loss of E-cadherin-mediated cell-cell adhesion is an essential event for the invasion of epithelial tumor cells (Cavallaro and Christofori, 2004) . In colon cancer, downregulation of E-cadherin expression is associated with higher histological grade and a worse prognosis (Van Aken et al., 1993) . Reduced E-cadherin expression in colon tumor cells allows cells to invade into collagen and Matrigel (Kinsella et al., 1994) . Transcriptional regulation is one of the regulatory steps in controlling E-cadherin expression. It appears that Pdcd4 regulates E-cadherin expression since both mRNA and protein levels of E-cadherin decreased when Pdcd4 expression was knocked down (Figure 4 and Supplementary Figure S3) . Several transcriptional repressors have been well characterized to regulate E-cadherin transcription (Peinado et al., 2004) . Since Pdcd4 functions as translation suppressor (Yang et al., 2003a (Yang et al., , 2004 , it is possible that Pdcd4 translationally suppresses these transcriptional repressor(s). Thus, downregulation of Pdcd4 might result in elevation of transcriptional repressor level and reduction of E-cadherin expression.
Given that E-cadherin is a binding partner of b-catenin, a decrease in E-cadherin expression results in an increase of cytoplasmic-free b-catenin. The cytoplasmic b-catenin will translocate into the nucleus if the APC is mutated or GSK-3b activity is blocked by Wnt signaling. In the nucleus, b-catenin binds with Tcf/LEF protein family and stimulates the expression of various genes involved in cell invasion, such as uPAR (Mann et al., 1999) . We demonstrated that Pdcd4 knockdown results in the accumulation of b-catenin in the nuclei (Figure 6 ), b-catenin binding with Tcf4 ( Figure 7a ) and activation of b-catenin/Tcf-dependent transcription (Figure 7b ). Therefore, activation of b-catenin/Tcfdependent transcription is one of the underlying mechanisms promoting invasion in Pdcd4 knockdown colon tumor cells. A recent study has shown that transiently knockdown of Pdcd4 in colon GEO cells increased the uPAR expression (Leupold et al., 2007) . Although the study implicated that Pdcd4 regulated uPAR expression via Sp1/Sp3, activated b-catenin/ Tcf-dependent transcription may also contribute to the upregulation of uPAR expression especially in Pdcd4 stably knockdown cells. It is thus possible that activation of b-catenin/Tcf-dependent transcription in Pdcd4 knockdown cells leads to upregulation of uPAR expression, which ultimately contributes to tumor cell invasion.
Another possible mechanism for promoting colon tumor cell invasion by Pdcd4 knockdown is through the activation of AP-1-dependent transcription (Figure 8a ). AP-1 controls the expression of numerous genes that are involved in regulation of tumor cell invasion (Ozanne et al., 2000) . Increased expression of AP-1 component proteins or stimulation of AP-1 activity has demonstrated to enhance invasion (Hennigan et al., 1994) . Conversely, inactivation of AP-1 activity by dominantnegative c-Jun, TAM67, inhibits invasion (Lamb et al., 1997; Yuspa, 1998) . Thus, activation of AP-1-dependent transcription by Pdcd4 knockdown (Figure 8a ) may contribute to promoting invasion. Previously, we and others demonstrated that Pdcd4 inhibits AP-1-dependent transcription via inhibiting c-Jun activation (Yang et al., 2003b (Yang et al., , 2006a Bitomsky et al., 2004) . Interestingly, Pdcd4 knockdown does not increase the levels of phospho-JNK and phospho-c-Jun, but increases c-Jun protein level (Figure 8b ), indicating that elevated c-Jun protein level contributes to activation of AP-1-dependent transcription upon Pdcd4 knockdown. Since c-Jun is one of the target genes of b-catenin/Tcfdependent transcription (Mann et al., 1999) , activation of b-catenin/Tcf-dependent transcription may stimulate c-Jun expression. It is also possible that Pdcd4 knockdown may activate c-Fos, which, in turn, activates AP-1-dependent transcription, since Pdcd4 also inhibits c-Fos activation (Yang et al., 2003b) . The detailed mechanism of how AP-1-dependent transcription is activated by Pdcd4 knockdown requires further investigation.
In conclusion, downregulation of Pdcd4 expression is sufficient to promote tumor invasion and alter the cell morphology. These phenotypic changes are attributed at least, in part, to the consequent downregulation of E-cadherin expression and activation of b-catenin/ Tcf-dependent and AP-1-dependent transcription. As Pdcd4 expression is frequently downregulated in the human colon cancer tissues, this study provides functional and mechanistic insight into the role of Pdcd4 in colon cancer progression.
Materials and methods
Cell culture HT29 (ATCC) and GEO (kindly provided by Douglas Boyd, MD Anderson Cancer Center) cells were grown in McCoy's 5A medium containing 10% FBS at 37 1C in a humidified atmosphere of 5% CO 2 in air.
Tissue microarrays
Human colon tissue array slides were purchased from Imgenex (IMH-306, IMH-339 and IMH-359) and Cybrdi (CC05-02). The slides were dewaxed and hydrated according to the manufacturer's protocol. Slides were then immunohistochemically stained with pre-immune and Pdcd4 antibody, tagged with peroxidase coupled secondary antibody and stained with 3,3 0 diamonobenzidine. Then the slides were counterstained with hematoxylin to locate nucleus.
Plasmids construction, virus production and transduction
The pdcd4 shRNA and lacZ shRNA lentivirus expression plasmids were created by using BLOCK-iT U6 RNAi Entry Vector Kit (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocol and named as pLenti-shPdcd4 and pLenti-shLacZ, respectively. The recombinant lentiviral particles were generated using the BLOCK-iT Lentiviral RNAi Expression System according to the manufacturer's protocol (Invitrogen). The viral supernatant was added to HT29 cells at a MOI of 25 containing 6 mg ml À1 of polybrene and selected by blasticidin (8 mg ml
À1
) for 30 days.
Quantitative real-time PCR (qPCR)
The total RNA was isolated from cells using Trizol reagent (Invitrogen). After synthesis of the first-strand cDNA using Superscript First-Strand Kit (Invitrogen), the Pdcd4, Ecadherin, or GAPDH mRNA levels were quantified by qPCR. The qPCR cycling was performed at 95 1C for 5 min followed by 40 cycles of denaturation (95 1C for 15 s), annealing (61 1C for 30 s) and extension (72 1C for 20 s). The target mRNA level was calculated as described previously (Portereiko et al., 2006) .
Matrigel invasion assay
Cells (1 Â 10 5 cells per well) were seeded onto Matrigel-coated Transwell filters (8-mm pore size) in Biocoat Matrigel invasion chambers (BD Biosciences, San Jose, CA, USA) and Matrigel invasion assay was conducted as described previously (Yang et al., 2006a) . The number of cells invaded onto the lower side of the membrane was determined by counting seven random areas.
Preparation of membrane, cytoplasmic and nuclear extracts The membrane and cytoplasmic extracts were prepared using Mem-PER eukaryotic membrane protein extraction reagent kit (Pierce) according to the manufacturer's protocol. After partition, the hydrophobic phase contains membrane proteins and the hydrophilic phase contains membrane inner surface associated proteins and soluble cytoplasmic proteins. Both phases were then dialysed against Tris buffer [50 mM Tris-HCl (pH 8.0), 100 mM NaCl and 0.5% NP-40]. Nuclear extracts were prepared using Dignam's method (Dignam et al., 1983) .
Immunoprecipitation and immunoblotting
Immunoblotting was performed as described previously (Yang et al., 2001 (Yang et al., , 2003a with antibodies against Pdcd4, E-cadherin (Santa Cruz Biotechnology, Santa Cruz, CA, USA), b-catenin (Chemicon, Temecula, CA, USA) active b-catenin (Upstate, Temecula, CA, USA), Tcf4 (Santa Cruz), phospho-c-Jun (Cell Signaling, Danvers, MA, USA), c-Jun (Cell Signaling) and phospho-ERK (Cell Signaling). The corresponding membrane was stripped and re-probed with GAPDH (Calbiochem, San Diego, CA, USA) or b-actin (Sigma, St Louis, MO, USA) followed by horseradish peroxidase-linked secondary antibody. The band intensity of the target protein was quantified using VisionWorks LS image acquisition and analysis software (UVP, Upland, CA, USA). Experiments were repeated twice using different preparations of samples.
Cell transfection and luciferase activity assays Cells (2 Â 10 4 cells per well in 24-well plates) were transiently transfected with 0.25 mg of TOPflash (Upstate), FOPflash (Upstate), AP-1-Luc, or NF-kB-Luc along with 10 ng of pRL-SV40 (Promega, Madison, WI, USA) using Fugene 6 reagent (Roche Molecular Biochemicals, Indianapolis, IN, USA). The luciferase activity was measured as described previously (Yang et al., 2001) . The luciferase activity of each sample is normalized against Renilla luciferase activity for monitoring transfection efficiency.
For overexpression of E-cadherin, 10 mg of E-cadherin expression plasmid (Origene, Rockville, MD, USA)was transiently transfected into 5 Â 10 5 HT29-shPdcd4 cells using Fugene 6. Cells were collected 72-h post-transfection for immunoblotting and Matrigel invasion assays.
